Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical Cancer
Clinical trial NCT05173272 · RECRUITING
Trial details
- NCT number
- NCT05173272
- Sponsor
- Sichuan Cancer Hospital and Research Institute
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-24
- Primary completion
- 2027-12-28
- Enrollment
- 286
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.